AbbVie (ABBV) Non Operating Income (2012 - 2026)

AbbVie (ABBV) has 15 years of Non Operating Income data on file, last reported at -$2.3 billion in Q1 2026.

• Non Operating Income for Q1 2026 came in at -$2.3 billion, down 59.58% year-over-year; the trailing twelve-month figure through Mar 2026 was -$6.7 billion (down 62.43% YoY), and the FY2025 annual result was -$5.8 billion, down 78.8% from the prior year.
• Non Operating Income retreated to -$2.3 billion in Q1 2026 per ABBV's latest filing, from -$1.2 billion in the prior quarter.
• Over five years, Non Operating Income peaked at $776.0 million in Q1 2022 and troughed at -$2.6 billion in Q2 2025.
• A 5-year average of -$1.1 billion and a median of -$1.3 billion in 2024 frame the typical range for Non Operating Income.
• The sharpest annual moves came in 2022 and 2024: Non Operating Income soared 1671.43% in 2022, then sank 1320.0% in 2024.
• A 5-year view of Non Operating Income shows it stood at -$2.0 billion in 2022, then increased by 23.01% to -$1.6 billion in 2023, then soared by 90.36% to -$150.0 million in 2024, then sank by 706.67% to -$1.2 billion in 2025, then sank by 90.58% to -$2.3 billion in 2026.
• Business Quant data shows ABBV's Non Operating Income at -$2.3 billion in Q1 2026, -$1.2 billion in Q4 2025, and -$503.0 million in Q3 2025.